IGHE and Alzheimer disease: However, clinical trials (Chronos) showed that the therapeutic effect of dupilumab on AD did not depend on the serum levels of IgE or TARC (data from clinical trials; Dupiumab Common Technical Document Part 2—Clinical Overview 2.7.3 Clinical Effectiveness).